Market Overview

Cardiome Pharma Halted News Pending

Share:
Related CRME
Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency
Cardiome Reports ~$15M Bought-Deal Financing

Posted-In: News

 

Related Articles (CRME)

View Comments and Join the Discussion!

Get Benzinga's Newsletters